{
  "meta": {
    "data_length": 1,
    "message": "Proposition id 647 retrieved successfully",
    "request_url": "http://api.moalmanac.org/propositions?proposition_id=647",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.012534,
    "timestamp_received": "2026-04-23T20:31:40.149051+00:00Z",
    "timestamp_returned": "2026-04-23T20:31:40.161585+00:00Z",
    "trace_id": "be602b46-75dd-4b30-9f44-bdc5d2bb9661"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-04-09"
  },
  "data": [
    {
      "id": 647,
      "type": "VariantTherapeuticResponseProposition",
      "predicate": "predictSensitivityTo",
      "biomarkers": [
        {
          "id": 56,
          "name": "PD-L1 (CPS) >= 5",
          "genes": [],
          "type": "CategoricalVariant",
          "extensions": [
            {
              "name": "biomarker_type",
              "value": "Protein expression"
            },
            {
              "name": "present",
              "value": true
            },
            {
              "name": "marker",
              "value": "PD-L1"
            },
            {
              "name": "unit",
              "value": "Combined Positive Score (CPS)"
            },
            {
              "name": "equality",
              "value": ">="
            },
            {
              "name": "value",
              "value": "5"
            }
          ]
        },
        {
          "id": 2,
          "name": "HER2-negative",
          "genes": [],
          "type": "CategoricalVariant",
          "extensions": [
            {
              "name": "biomarker_type",
              "value": "Protein expression"
            },
            {
              "name": "present",
              "value": true
            },
            {
              "name": "marker",
              "value": "Human epidermal growth factor receptor 2 (HER2)"
            },
            {
              "name": "unit",
              "value": "status"
            },
            {
              "name": "equality",
              "value": "="
            },
            {
              "name": "value",
              "value": "Negative"
            }
          ]
        }
      ],
      "subjectVariant": {},
      "conditionQualifier": {
        "id": 81,
        "conceptType": "Disease",
        "name": "Esophagogastric Adenocarcinoma",
        "primaryCoding": {
          "id": "oncotree:EGC",
          "code": "EGC",
          "name": "Esophagogastric Adenocarcinoma",
          "system": "https://oncotree.mskcc.org",
          "systemVersion": "oncotree_2021_11_02",
          "iris": [
            "https://oncotree.mskcc.org/?version=oncotree_2021_11_02&field=CODE&search=EGC"
          ]
        },
        "mappings": []
      },
      "objectTherapeutic": {
        "id": 130,
        "membership_operator": "AND",
        "therapies": [
          {
            "id": 72,
            "conceptType": "Drug",
            "name": "Nivolumab",
            "primaryCoding": {
              "id": "ncit:C68814",
              "code": "C68814",
              "name": "Nivolumab",
              "system": "https://evsexplore.semantics.cancer.gov",
              "systemVersion": "25.01d",
              "iris": [
                "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C68814"
              ]
            },
            "mappings": [],
            "extensions": [
              {
                "name": "therapy_strategy",
                "value": [
                  "PD-1/PD-L1 inhibition"
                ],
                "description": "Associated therapeutic strategy or mechanism of action of the therapy."
              },
              {
                "name": "therapy_type",
                "value": "Immunotherapy",
                "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
              }
            ]
          },
          {
            "id": 28,
            "conceptType": "Drug",
            "name": "Oxaliplatin",
            "primaryCoding": {
              "id": "ncit:C1181",
              "code": "C1181",
              "name": "Oxaliplatin",
              "system": "https://evsexplore.semantics.cancer.gov",
              "systemVersion": "25.01d",
              "iris": [
                "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C1181"
              ]
            },
            "mappings": [],
            "extensions": [
              {
                "name": "therapy_strategy",
                "value": [
                  "Platinum-based chemotherapy"
                ],
                "description": "Associated therapeutic strategy or mechanism of action of the therapy."
              },
              {
                "name": "therapy_type",
                "value": "Chemotherapy",
                "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
              }
            ]
          }
        ]
      }
    }
  ]
}